Daniel R Marshak's Net Worth

$8.21 Million

Estimate Recalculated May 2, 2024 03:10PM EST

Who is Daniel R Marshak?

Daniel R Marshak has an estimated net worth of $8.21 Million. This is based on reported shares across multiple companies, which include PERKINELMER INC, CAMBREX CORP, and INVIVO THERAPEUTICS HOLDINGS CORP..

SEC CIK

Daniel R Marshak's CIK is 0001192624

Past Insider Trading and Trends

2014 was Daniel R Marshak's most active year for acquiring shares with 10 total transactions. Daniel R Marshak's most active month to acquire stocks was the month of January. 2014 was Daniel R Marshak's most active year for disposing of shares, totalling 14 transactions. Daniel R Marshak's most active month to dispose stocks was the month of January. 2014 saw Daniel R Marshak paying a total of $1,566,002.04 for 207,359 shares, this is the most they've acquired in one year. In 2014 Daniel R Marshak cashed out on 146,927 shares for a total of $2,030,458.05, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PERKINELMER INC (RVTY) Snapshot price: $103.14

SVP & CSO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-22.50%
-19.67K
—
—
67.74K
Sep 26
Form 4
+92.34%
41.97K
$18.98
$796,425.71
87.41K
Aug 6
Form 4
—
0
$34.52
-$2,702.00
45.45K
Scheduled
Jul 7
Form 4
—
0
$30.48
-$420,660.00
45.45K
Scheduled
Jul 2
Form 4
—
0
$29.78
-$336,520.00
45.45K
Scheduled
Jun 26
Form 4
—
0
$35.16
-$391,068.13
45.45K
Scheduled
Mar 12
Form 4
-5.24%
-2.51K
$43.78
-$109,931.58
45.45K
Feb 10
Form 4
+12.15%
5.19K
—
—
47.96K
Feb 4
Form 4
—
0
$31.52
-$196,633.62
42.76K
Scheduled
Dec 10
Form 4
—
0
$27.88
-$221,400.00
42.76K
Scheduled
Mar 8
Form 4
-6.94%
-3.19K
$34.73
-$110,715.14
42.76K
Feb 8 - Feb 11
Form 4
+16.05%
6.36K
—
—
45.95K
Feb 5
Form 4
+24.77%
7.86K
$26.18
-$6,702.08
39.59K
Feb 7 - Feb 8
Form 4
-3.49%
-1.15K
$24.12
-$27,689.76
31.73K
Jan 27
Form 4
-0.50%
-164.00
$26.33
-$4,318.12
32.86K
Feb 28
Form 4
+39.27%
9.31K
—
—
33.03K
Feb 8
Form 4
-14.96%
-4.17K
$25.18
-$28,931.82
23.71K
Jan 20
Form 4
-8.03%
-2.43K
$22.02
-$53,594.25
27.89K
Feb 26
Form 4
+42.34%
8.98K
—
—
30.18K
Feb 9
Form 4
-11.92%
-2.87K
$20.37
-$58,421.16
21.2K
Jan 26
Form 4
+66.30%
9.59K
—
—
24.04K
Feb 3
Form 3
—
0
—
—
0
No matching records found

CAMBREX CORP No price found

Vice President

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-22.75%
-1.05K
$19.31
-$20,372.05
3.58K
Feb 27
Form 4
+79.82%
1.59K
—
—
3.58K
Jan 26
Form 4
—
0
—
—
0
Jul 25
Form 4
-100.00%
-1.23K
$23.60
-$28,957.20
0
Mar 1
Form 4
+39.49%
1.21K
—
—
4.27K
Jan 27
Form 4
—
0
—
—
0
Aug 23
Form 4
+50.75%
782
—
—
2.32K
Jan 22
Form 4
—
0
—
—
0
No matching records found

INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV) Snapshot price: $0.608999

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Nov 17
Form 4
—
0
—
—
0
Mar 18
Form 4
—
0
—
—
0
Jan 19
Form 4
—
0
—
—
0
Jan 18
Form 4
—
0
—
—
0
Dec 10
Form 4
—
0
—
—
0
Dec 10
Form 4
—
0
—
—
0
Sep 29
Form 3
—
0
—
—
0
No matching records found